Home | About ABSG | About Xcenda | Contact Us

  Newsletter

 

  Existing Members

  Sponsors

  Become a Member/Sponsor



  For more information, please contact:

  Timothy S. Regan, RPh, CPh
  Executive Director
  Phone: (727) 771-4129
  Fax: (727) 771-4145
  tim.regan@xcenda.com



 

 

 



Based upon your interest, expertise, and available time, the following additional collaboration opportunities are available for MCN members:

Web-surveys
MCN members are often invited to participate in web-based surveys throughout the calendar year. These surveys focus on a variety of issues however many clients use these surveys as a pulse on issues requiring immediate attention. These surveys offer MCN members another confidential venue to influence the U.S. pharmaceutical market.

Focus Groups / Advisory Boards
In addition to the large group setting, MCN members also have the opportunity to participate in small focus groups and advisory boards. These focus groups may occur within standing MCN quarterly meetings, as “stand alone” live advisory boards, and may be convened as “virtual” meetings using WebEx technology.

Naturalistic Studies / Database Research
MCN advisors may choose to collaborate in the design/development or participate in outcomes research, comparative effectiveness, patient reported outcomes and other sponsored research projects.

Quality Improvement Programs
MCN members may choose to participate in sponsored multi-site quality improvement demonstration projects that seek to provide data-driven, evidence-based solutions to improve the quality and cost-effectiveness of patient care.

Models / Outcomes Analyzers
If cost-effectiveness analysis, budget impact models, or other excel-based and/or software is your area of interest/expertise, MCN offers opportunities for members to serve as advisors in the development of credible, user-friendly, transparent, and useful decision-support tools.

Manuscript / Dossiers
MCN members may choose to collaborate by serving as a co-author or reviewer for scientific posters, manuscripts, formulary dossiers, and other publications.